NuVasive
NUVA
#4598
Rank
A$3.13 B
Marketcap
A$59.84
Share price
0.00%
Change (1 day)
3.93%
Change (1 year)
Categories

Revenue for NuVasive (NUVA)

Revenue in 2023 (TTM): A$1.84 Billion

According to NuVasive's latest financial reports the company's current revenue (TTM ) is A$1.84 Billion. In 2022 the company made a revenue of A$1.76 Billion an increase over the revenue in the year 2021 that were of A$1.57 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for NuVasive from 2004 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) A$1.84 B4.42%
2022 A$1.76 B12.42%
2021 A$1.57 B14.99%
2020 A$1.36 B-18.1%
2019 A$1.66 B6.68%
2018 A$1.56 B18.59%
2017 A$1.31 B-1.2%
2016 A$1.33 B19.87%
2015 A$1.11 B19.52%
2014 A$0.93 B21.28%
2013 A$0.76 B28.7%
2012 A$0.59 B13.22%
2011 A$0.52 B11.97%
2010 A$0.47 B14.2%
2009 A$0.41 B16.3%
2008 A$0.35 B100.87%
2007 A$0.17 B41.82%
2006 A$0.12 B47.35%
2005 A$84.44 M70.16%
2004 A$49.62 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Orthofix Medical
OFIX
A$1.23 B-33.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
A$36.70 B 1,888.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Globus Medical
GMED
A$4.16 B 125.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$51.48 B 2,689.05%๐Ÿ‡ฎ๐Ÿ‡ช Ireland